Alafi Capital Co Llc, Ten Percent Owner at Intra-Cellular Therapies, holds 3.60M shares in Intra-Cellular Therapies (Ticker: ITCI), holds 2.33M shares in Stereotaxis (Ticker: STXS). Most recently, Alafi Capital Co Llc Bought ― shares of Intra-Cellular Therapies on Oct 03, 2017 for an estimated value of 4.00M.
What is the percentage of profitable transactions made by Alafi Capital Co Llc?
The percentage of profitable transactions made by Alafi Capital Co Llc is 88%.
What is the average return per transaction made by Alafi Capital Co Llc?
The average return per transaction made by Alafi Capital Co Llc is 163.40%.
What stocks does Alafi Capital Co Llc hold?
Alafi Capital Co Llc holds: ITCI, STXS stocks.
What was Alafi Capital Co Llc’s latest transaction?
Alafi Capital Co Llc latest transaction was an Informative Buy of $4.00M.
What was Alafi Capital Co Llc's most profitable transaction?
Alafi Capital Co Llc’s most profitable transaction was an Informative Buy of ITCI stock on November 28, 2014. The return on the trade was 308.90%.
What is Alafi Capital Co Llc's role in Intra-Cellular Therapies?
Alafi Capital Co Llc's role in Intra-Cellular Therapies is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.